Trials / Unknown
UnknownNCT01334697
Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers
Phase I, Randomized, Multicenter, Double-blind, Single Dose, Dose-Escalation, Placebo-Controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous Administration of Cardiotrophin-1 (CT-1)in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Digna Biotech S.L. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The general aim of the study is to determinate safety, tolerability and early pharmacokinetics of cardiotrophin.1 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | recombinant human cardiotrophin-1 | Single dose intravenous administration |
| OTHER | Placebo | Single dose intravenous administration |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2011-04-13
- Last updated
- 2013-07-30
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01334697. Inclusion in this directory is not an endorsement.